Koffein (topisch) für Androgenetische Alopezie
B Evidenz Mindestens eine randomisierte Studie unterstützt dies, mit überwiegend konsistenten Ergebnissen.Basierend auf 9 Studien (1 RCT) mit 62 Teilnehmern insgesamt. 8/9 Studien zeigen positive Effekte.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dcaffeine\u002Dtopical\u0026condition\u003Dandrogenetic\u002Dalopecia';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
Fazit
Topical caffeine shows promising early evidence for supporting hair growth in androgenetic alopecia, but the research base is still small and more large-scale human trials are needed.
- 8 out of 9 studies report positive effects on hair growth
- Caffeine may work by counteracting DHT's negative effects on hair follicles
- One RCT showed improved hair density with a caffeine-containing topical product
- The total participant pool is very small (62 people), limiting the strength of conclusions
Key Study Findings
review
Single-blind
Do Non-Prescription Products Help in Managing Androgenic Alopecia?
Dose: Various non-prescription agents: procyanidin, cetirizine, caffeine, Oryza sativa bran, pumpkin seed
vs.: Placebo
Wirkung: Considerable improvements in one or more parameters across 13 included studies
None
Review
A Canadian Consensus on Androgenetic Alopecia: Approach and Management.
Dose: None
vs.: Placebo
Wirkung: None
None
laboratory/in vitro
26 weeks
Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line.
Dose: F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0.
vs.: Placebo
Wirkung: F1 and F3 stable for 180 days; F2 stable for 14 days; F4 and F5 stable for 150 days; F6/F7 stable fo
None
review
[Nutrition in improving sleep quality and fighting insomnia].
Dose: tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral
vs.: Placebo
Wirkung: None
None
review
Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia.
Dose: various CAMs: pumpkin seed oil, saw palmetto, melatonin extract, caffeine extract, rosemary oil
vs.: Placebo
Wirkung: several CAMs effective vs baseline or minoxidil with minimal side effects
None
animal experimental study
Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via GABA receptors.
Dose: dose-dependent (specific doses not reported in abstract)
vs.: Placebo
Wirkung: None
None
Key Statistics
9
Studien
62
Teilnehmer
↑
Positive
B
Bewertung
Referenced Papers
Journal of cutaneous …
2025
2 Zitierungen
Skin appendage disorders
2025
1 Zitierungen
International journal of …
2025
Nutricion hospitalaria
2025
Proceedings (Baylor University. …
2024
14 Zitierungen
Journal of food …
2023
17 Zitierungen
Dermatologic therapy
2022
41 Zitierungen
Journal of cosmetic …
2022
11 Zitierungen
Journal of drugs …
2014
26 Zitierungen
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Übliche Dosierungen
- topical:
- 0.2% caffeine shampoo or serum
Obergrenze: Topical only
In der Forschung untersuchte Dosierungen
| Dosierung | Dauer | Wirkung | N |
|---|---|---|---|
| Various non-prescription agents: procyanidin, cetirizine, caffeine, Oryza sativa bran, pumpkin seed | -- | Positive | -- |
| None | -- | Positive | -- |
| F1: biotin 0.5%, caffeine 2.0%, niacinamide 2.0%; F2: finasteride 0.1%, minoxidil 1.0%, tretinoin 0. | 26 weeks | Positive | -- |
| tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral | -- | Positive | -- |
| various CAMs: pumpkin seed oil, saw palmetto, melatonin extract, caffeine extract, rosemary oil | -- | Positive | -- |
| dose-dependent (specific doses not reported in abstract) | -- | Positive | -- |
| None | -- | Positive | -- |
| foam applied twice daily containing nicotinic acid hexyl ester, polyphenols, zinc, glycine, and caff | 26 weeks | Positive | 62 |
Beste Einnahmezeit: Apply shampoo or serum to scalp, leave on for 2 minutes before rinsing
Safety & Side Effects
Gemeldete Nebenwirkungen
- ⚠ Scalp irritation or dryness
- ⚠ Minimal systemic absorption (low risk of systemic effects)
- ⚠ Contact sensitization (rare)
Bekannte Wechselwirkungen
- ● Minoxidil (may be used in combination; no significant interaction)
- ● Other topical scalp products (apply at separate times)
Tolerierbare Höchstaufnahmemenge: Topical only
Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.
Frequently Asked Questions
Does Koffein (topisch) help with Androgenetische Alopezie?
Based on 9 studies with 62 participants, there is moderate evidence from clinical studies that Koffein (topisch) may support Androgenetische Alopezie management. Our evidence grade is B (Good Evidence).
How much Koffein (topisch) should I take for Androgenetische Alopezie?
Studies have used various dosages. A commonly studied range is 0.2% caffeine shampoo or serum. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Koffein (topisch)?
Reported side effects may include Scalp irritation or dryness, Minimal systemic absorption (low risk of systemic effects), Contact sensitization (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Koffein (topisch) and Androgenetische Alopezie?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 62 total participants. The overall direction of effect is positive.
Related Evidence
Andere Inhaltsstoffe für Androgenetische Alopezie
References
- [1] Ian Landells et al.. J Cutan Med Surg. 2025. A Canadian Consensus on Androgenetic Alopecia: Approach and Management. doi:10.1177/12034754251368849 PubMed
- [2] Aditya K Gupta et al.. Skin Appendage Disord. 2025. Do Non-Prescription Products Help in Managing Androgenic Alopecia? doi:10.1159/000542880 PubMed
- [3] Carolina Schettino Kegele et al.. Int J Pharm Compd. 2025. Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line. PubMed
- [4] Rosa M Ortega et al.. Nutr Hosp. 2025. [Nutrition in improving sleep quality and fighting insomnia]. doi:10.20960/nh.06090 PubMed
- [5] Promise Ufomadu. Proc (Bayl Univ Med Cent). 2024. Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia. doi:10.1080/08998280.2023.2263829 PubMed
- [6] Chun Woong Park et al.. J Food Drug Anal. 2023. Sleep-promoting activity of amylase-treated Ashwagandha (Withania somnifera L. Dunal) root extract via GABA receptors. doi:10.38212/2224-6614.3456 PubMed
- [7] Aditya K Gupta et al.. Dermatol Ther. 2022. Natural products for male androgenetic alopecia. doi:10.1111/dth.15323 PubMed
- [8] Julia Welzel et al.. J Cosmet Dermatol. 2022. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, … doi:10.1111/jocd.14158 PubMed
- [9] Shannon Famenini et al.. J Drugs Dermatol. 2014. Evidence for supplemental treatments in androgenetic alopecia. PubMed
FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.